<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01314313</url>
  </required_header>
  <id_info>
    <org_study_id>2010-12-PIIA</org_study_id>
    <nct_id>NCT01314313</nct_id>
  </id_info>
  <brief_title>The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII A</brief_title>
  <acronym>PARTNERII A</acronym>
  <official_title>The PARTNER II Trial &quot;Placement of AoRTic TraNscathetER&quot; Valves Trial&quot; (US) [PII A]</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN
      XT transcatheter heart valve and delivery systems which are intended for use in patients with
      symptomatic, calcific, severe aortic stenosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The PIIA cohort is a prospective multi-center trial undergoing aortic valve replacement for
      severe aortic stenosis. Patients randomized to the treatment arm will receive an Edwards
      SAPIEN XT THV with either transfemoral, transapical or transaortic delivery access. Patients
      in the control arm will receive a surgical bioprosthetic heart valve via aortic valve
      replacement surgery.

      To assure that patients with an STS score ≥ 4% have been selected.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 2011</start_date>
  <completion_date type="Anticipated">November 2024</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause Death or Disabling Stroke to Two Years</measure>
    <time_frame>2 Years</time_frame>
    <description>All-cause Death or Disabling Stroke (Edwards SAPIEN XT THV vs SAVR)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adjusted Days Alive and Out of Hospital (DAOH) to Two Years</measure>
    <time_frame>2 years</time_frame>
    <description>The number of days the patients are alive and out of the hospital.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Aortic Regurgitation (AR) at 2 Years</measure>
    <time_frame>2 years</time_frame>
    <description>Total aortic regurgitation was assessed by the core lab as &quot;Grade 0&quot; = None, &quot;Grade 1+&quot; = Trace, &quot;Grade 2+&quot; = Mild, &quot;Grade 3+&quot; = Moderate and &quot;Grade 4+&quot; = Severe. Total regurgitation at two year was analyzed in the valve implant population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6MWT Change From Baseline</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Six Minute Walk Test change from baseline to 2 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA Classification at 2 Years</measure>
    <time_frame>2 years</time_frame>
    <description>New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effective Orifice Area (EOA)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2032</enrollment>
  <condition>Symptomatic Severe Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>PIIA - SAPIEN XT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIIA is operable group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control: SAVR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SAVR (surgical aortic valve replacement) is the control arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TAVR Implantation with SAPIEN XT</intervention_name>
    <description>Operable Group with SAPIEN XT</description>
    <arm_group_label>PIIA - SAPIEN XT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SAVR Implantation</intervention_name>
    <description>Control Group</description>
    <arm_group_label>Control: SAVR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          1. Patient has senile degenerative aortic valve stenosis with echocardiographically
             derived criteria: mean gradient &gt;40 mmHg or jet velocity greater than 4.0 m/s and an
             initial aortic valve area (AVA) of ≤0.8 cm2 or indexed EOA &lt; 0.5 cm2/m2 Qualifying
             echo must be within 60 days of the date of the procedure.

          2. Patient is symptomatic from his/her aortic valve stenosis, as demonstrated by NYHA
             Functional Class II or greater.

          3. The heart team agrees (and verified in the case review process) that valve
             implantation will likely benefit the patient.

          4. The study patient or the study patient's legal representative has been informed of the
             nature of the study, agrees to its provisions and has provided written informed
             consent as approved by the Institutional Review Board (IRB) of the respective clinical
             site.

          5. The study patient agrees to comply with all required post-procedure follow-up visits
             including annual visits through 5 years and analysis close date visits, which will be
             conducted as a phone follow-up.

          6. Study patient agrees to undergo surgical aortic valve replacement (SAVR) - if
             randomized to control treatment.

        Exclusion Criteria

          1. Evidence of an acute myocardial infarction ≤ 1 month (30 days) before the intended
             treatment [defined as: Q wave MI, or non-Q wave MI with total CK elevation of CK-MB ≥
             twice normal in the presence of MB elevation and/or troponin level elevation (WHO
             definition)].

          2. Aortic valve is a congenital unicuspid or congenital bicuspid valve, or is
             non-calcified.

          3. Mixed aortic valve disease (aortic stenosis and aortic regurgitation with predominant
             aortic regurgitation &gt;3+).

          4. Preexisting mechanical or bioprosthetic valve in any position (except NR3).

          5. Any therapeutic invasive cardiac procedure resulting in a permanent implant that is
             performed within 30 days of the index procedure (unless part of planned strategy for
             treatment of concomitant coronary artery disease). Implantation of a permanent
             pacemaker or ICD (S3 Cohort only) is not excluded.

          6. Heart team assessment of inoperability (including examining cardiac surgeon).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin B Leon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Craig Smith, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arkansas Heart Hospital/Clinic</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scripps Green Hospital</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scripps Memorial Hospital</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy General Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UC Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morton Plant Hospital</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami Hospital Miller School of Medicine</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northshore</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prairie Education and Research Cooperative</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University Health-Methodist Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Jewish Hospital Medical Center</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic Foundation</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Maryland, Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minneapolis Heart Institute Foundation</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic-Saint Marys Hospital</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Hospital - Mid America Heart Institute</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University - Barnes Jewish Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nebraska Heart Institute</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68526</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cooper University</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newark Beth Israel Medical Center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Winthrop University Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Hospital - Cornell</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Carolina Heart Institute at East Carolina University</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Lindner Center for Research &amp; Education at The Christ Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oklahoma Cardiovascular Research Group</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Heart &amp; Vascular Institute at Providence St. Vincent Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>York Hospital</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Memorial Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Heart, PLLC</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Heart Hospital Baylor Plano</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical City Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center at San Antonio (UTHSCSA)</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229-3900</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IHC Health Services Inc. dba Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin - Madison</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Paul's Hospital, Providence Health Care</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Universitaire de Cardiologie et de Pneumologie de Québec</name>
      <address>
        <city>Quebec</city>
        <zip>G1V465</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>March 7, 2011</study_first_submitted>
  <study_first_submitted_qc>March 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2011</study_first_posted>
  <results_first_submitted>September 16, 2016</results_first_submitted>
  <results_first_submitted_qc>July 17, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">August 14, 2018</results_first_posted>
  <last_update_submitted>August 26, 2019</last_update_submitted>
  <last_update_submitted_qc>August 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SAPIEN XT</keyword>
  <keyword>Transfemoral</keyword>
  <keyword>Transapical</keyword>
  <keyword>Transaortic</keyword>
  <keyword>NovaFlex</keyword>
  <keyword>TAVI</keyword>
  <keyword>Aortic Stenosis</keyword>
  <keyword>THV</keyword>
  <keyword>Aortic Valve</keyword>
  <keyword>Transcatheter Heart Valve</keyword>
  <keyword>TAVR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Between December 23, 2011 to November 6, 2013 2,032 patients were enrolled into the PARTNER II A SAPIEN XT vs SAVR Intermediate Risk Trial at 57 sites in the United States and Canada.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>PIIA: SAPIEN XT</title>
          <description>Edwards SAPIEN XT Transcatheter Heart Valve (THV)
NOTE: SAVR with surgical bioprosthetic heart valve is the control arm.</description>
        </group>
        <group group_id="P2">
          <title>Control: SAVR</title>
          <description>Surgical Aortic Valve Replacement (SAVR)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1011"/>
                <participants group_id="P2" count="1021"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>As Treated</title>
              <participants_list>
                <participants group_id="P1" count="994"/>
                <participants group_id="P2" count="944"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Valve Implanted</title>
              <participants_list>
                <participants group_id="P1" count="974"/>
                <participants group_id="P2" count="936"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="784"/>
                <participants group_id="P2" count="710"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="227"/>
                <participants group_id="P2" count="311"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>PIIA: SAPIEN XT</title>
          <description>Edwards SAPIEN XT Transcatheter Heart Valve (THV)</description>
        </group>
        <group group_id="B2">
          <title>Control: SAVR</title>
          <description>Surgical Aortic Valve Replacement (SAVR); Control for PIIA: SAPIEN XT</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1011"/>
            <count group_id="B2" value="1021"/>
            <count group_id="B3" value="2032"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81.5" spread="6.70"/>
                    <measurement group_id="B2" value="81.7" spread="6.71"/>
                    <measurement group_id="B3" value="81.6" spread="6.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="463"/>
                    <measurement group_id="B2" value="461"/>
                    <measurement group_id="B3" value="924"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="548"/>
                    <measurement group_id="B2" value="560"/>
                    <measurement group_id="B3" value="1108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>STS Score</title>
          <description>The Society of Thoracic Surgeons (STS) score measures patient risk at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.</description>
          <units>% risk of mortality or morbidity</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.8" spread="2.08"/>
                    <measurement group_id="B2" value="5.8" spread="1.87"/>
                    <measurement group_id="B3" value="5.8" spread="1.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>NYHA Classification</title>
          <description>New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>NYHA I/II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="229"/>
                    <measurement group_id="B2" value="244"/>
                    <measurement group_id="B3" value="473"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA III/VI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="782"/>
                    <measurement group_id="B2" value="776"/>
                    <measurement group_id="B3" value="1558"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>All-cause Death or Disabling Stroke to Two Years</title>
        <description>All-cause Death or Disabling Stroke (Edwards SAPIEN XT THV vs SAVR)</description>
        <time_frame>2 Years</time_frame>
        <population>Participants include all patients who were randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>PIIA: SAPIEN XT</title>
            <description>Edwards SAPIEN XT Transcatheter Heart Valve (THV)</description>
          </group>
          <group group_id="O2">
            <title>Control: SAVR</title>
            <description>Control: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>All-cause Death or Disabling Stroke to Two Years</title>
          <description>All-cause Death or Disabling Stroke (Edwards SAPIEN XT THV vs SAVR)</description>
          <population>Participants include all patients who were randomized.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1011"/>
                <count group_id="O2" value="1021"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="192"/>
                    <measurement group_id="O2" value="202"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adjusted Days Alive and Out of Hospital (DAOH) to Two Years</title>
        <description>The number of days the patients are alive and out of the hospital.</description>
        <time_frame>2 years</time_frame>
        <population>Intent to Treat Population: All randomized patients with the exception of Total Aortic Regurgitation and Effective Orifice Area which was analyzed with the Valve Implant Population: All randomized patients receiving the valve.</population>
        <group_list>
          <group group_id="O1">
            <title>PIIA: SAPIEN XT</title>
            <description>Edwards SAPIEN XT Transcatheter Heart Valve (THV)</description>
          </group>
          <group group_id="O2">
            <title>Control: SAVR</title>
            <description>Control: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Adjusted Days Alive and Out of Hospital (DAOH) to Two Years</title>
          <description>The number of days the patients are alive and out of the hospital.</description>
          <population>Intent to Treat Population: All randomized patients with the exception of Total Aortic Regurgitation and Effective Orifice Area which was analyzed with the Valve Implant Population: All randomized patients receiving the valve.</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="998"/>
                <count group_id="O2" value="953"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="629.4" spread="208.54"/>
                    <measurement group_id="O2" value="597.8" spread="236.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Aortic Regurgitation (AR) at 2 Years</title>
        <description>Total aortic regurgitation was assessed by the core lab as &quot;Grade 0&quot; = None, &quot;Grade 1+&quot; = Trace, &quot;Grade 2+&quot; = Mild, &quot;Grade 3+&quot; = Moderate and &quot;Grade 4+&quot; = Severe. Total regurgitation at two year was analyzed in the valve implant population.</description>
        <time_frame>2 years</time_frame>
        <population>All randomized patients who received the valve were analyzed. Note: Echos were not available for all the patients who made the follow-up visit.</population>
        <group_list>
          <group group_id="O1">
            <title>PIIA: SAPIEN XT</title>
            <description>Edwards SAPIEN XT Transcatheter Heart Valve (THV)</description>
          </group>
          <group group_id="O2">
            <title>Control: SAVR</title>
            <description>Control: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Total Aortic Regurgitation (AR) at 2 Years</title>
          <description>Total aortic regurgitation was assessed by the core lab as &quot;Grade 0&quot; = None, &quot;Grade 1+&quot; = Trace, &quot;Grade 2+&quot; = Mild, &quot;Grade 3+&quot; = Moderate and &quot;Grade 4+&quot; = Severe. Total regurgitation at two year was analyzed in the valve implant population.</description>
          <population>All randomized patients who received the valve were analyzed. Note: Echos were not available for all the patients who made the follow-up visit.</population>
          <units>Grade</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="606"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="1.0"/>
                    <measurement group_id="O2" value="0.5" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>6MWT Change From Baseline</title>
        <description>Six Minute Walk Test change from baseline to 2 years</description>
        <time_frame>Baseline and 2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PIIA: SAPIEN XT</title>
            <description>Edwards SAPIEN XT Transcatheter Heart Valve (THV)</description>
          </group>
          <group group_id="O2">
            <title>Control: SAVR</title>
            <description>Control: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>6MWT Change From Baseline</title>
          <description>Six Minute Walk Test change from baseline to 2 years</description>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="604"/>
                <count group_id="O2" value="1021"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.5" spread="128.7"/>
                    <measurement group_id="O2" value="NA" spread="NA">This secondary endpoint analyzes change within the SAPIEN XT Cohort.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>NYHA Classification at 2 Years</title>
        <description>New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.</description>
        <time_frame>2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PIIA: SAPIEN XT</title>
            <description>Intermediate Risk Surgical Patients: Transcatheter Heart Valve (THV)</description>
          </group>
          <group group_id="O2">
            <title>Control: SAVR</title>
            <description>Control: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>NYHA Classification at 2 Years</title>
          <description>New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="737"/>
                <count group_id="O2" value="649"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.7"/>
                    <measurement group_id="O2" value="1.4" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Effective Orifice Area (EOA)</title>
        <time_frame>2 years</time_frame>
        <population>Effective Orifice Area is listed for only the patients who had echo available at the follow-up visit.</population>
        <group_list>
          <group group_id="O1">
            <title>PIIA: SAPIEN XT</title>
            <description>Edwards SAPIEN XT Transcatheter Heart Valve (THV)</description>
          </group>
          <group group_id="O2">
            <title>Control: SAVR</title>
            <description>Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Effective Orifice Area (EOA)</title>
          <population>Effective Orifice Area is listed for only the patients who had echo available at the follow-up visit.</population>
          <units>cm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="573"/>
                <count group_id="O2" value="490"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.4"/>
                    <measurement group_id="O2" value="1.4" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data are currently available and reported for all events at 2 years were reported at the time of database lock.</time_frame>
      <desc>Adverse Events are site reported. Only Valve-Implanted patients are reported for all adverse events (except for mortality).</desc>
      <group_list>
        <group group_id="E1">
          <title>PIIA: SAPIEN XT - 2 Year</title>
          <description>Edwards SAPIEN XT Transcatheter Heart Valve (THV)</description>
        </group>
        <group group_id="E2">
          <title>Control: SAVR - 2 Year</title>
          <description>Surgical Aortic Valve Replacement (SAVR)
NOTE: SAVR with surgical bioprosthetic heart valve is the control arm.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 10.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="166" subjects_at_risk="1011"/>
                <counts group_id="E2" subjects_affected="170" subjects_at_risk="1021"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="666" subjects_at_risk="974"/>
                <counts group_id="E2" subjects_affected="672" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia/Hemolytic anemia</sub_title>
                <counts group_id="E1" events="26" subjects_affected="24" subjects_at_risk="974"/>
                <counts group_id="E2" events="43" subjects_affected="38" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="974"/>
                <counts group_id="E2" events="24" subjects_affected="24" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina/Cardiac chest pain</sub_title>
                <counts group_id="E1" events="28" subjects_affected="22" subjects_at_risk="974"/>
                <counts group_id="E2" events="30" subjects_affected="24" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Arrhythmia/Conduction system injury (defect)</sub_title>
                <counts group_id="E1" events="186" subjects_affected="170" subjects_at_risk="974"/>
                <counts group_id="E2" events="226" subjects_affected="196" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="33" subjects_affected="33" subjects_at_risk="974"/>
                <counts group_id="E2" events="38" subjects_affected="36" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade/Pericardial effusion</sub_title>
                <counts group_id="E1" events="21" subjects_affected="21" subjects_at_risk="974"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="974"/>
                <counts group_id="E2" events="20" subjects_affected="20" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Heart failure/CHF/Low output failure</sub_title>
                <counts group_id="E1" events="197" subjects_affected="127" subjects_at_risk="974"/>
                <counts group_id="E2" events="134" subjects_affected="103" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>MI</sub_title>
                <counts group_id="E1" events="29" subjects_affected="29" subjects_at_risk="974"/>
                <counts group_id="E2" events="30" subjects_affected="26" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Mitral valve injury or insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="974"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="974"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastro Intestinal event - Non-hemorrhagic</sub_title>
                <counts group_id="E1" events="77" subjects_affected="67" subjects_at_risk="974"/>
                <counts group_id="E2" events="65" subjects_affected="53" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic insufficiency/Regurgitation PV leak - Non structural dysfunction</sub_title>
                <counts group_id="E1" events="30" subjects_affected="24" subjects_at_risk="974"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Aortic insufficiency/Regurgitation PV leak - Structural dysfunction</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="974"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Aortic insufficiency/Regurgitation non valvular cause</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="974"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Coronary flow obstruction/Transvalvular flow disturbance</sub_title>
                <counts group_id="E1" events="9" subjects_affected="6" subjects_at_risk="974"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Device embolization</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="974"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Device migration/malposition requiring intervention</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="974"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Edema</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="974"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Exercise intolerance or weakness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="974"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Miscellaneous - Drug reaction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="974"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Miscellaneous - Other</sub_title>
                <counts group_id="E1" events="28" subjects_affected="22" subjects_at_risk="974"/>
                <counts group_id="E2" events="24" subjects_affected="23" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Miscellaneous - Suicide</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="974"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Multi organ failure</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="974"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" events="80" subjects_affected="70" subjects_at_risk="974"/>
                <counts group_id="E2" events="72" subjects_affected="68" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Unknown cause of death</sub_title>
                <counts group_id="E1" events="21" subjects_affected="21" subjects_at_risk="974"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Valve stenosis - Restenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="974"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Valve thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="974"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection - Access site infection</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="974"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Infection - Bacteremia</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="974"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Infection - Endocarditis</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="974"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Infection - Other</sub_title>
                <counts group_id="E1" events="48" subjects_affected="37" subjects_at_risk="974"/>
                <counts group_id="E2" events="67" subjects_affected="56" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Infection - Respiratory infection</sub_title>
                <counts group_id="E1" events="110" subjects_affected="93" subjects_at_risk="974"/>
                <counts group_id="E2" events="111" subjects_affected="100" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Infection - Sepsis</sub_title>
                <counts group_id="E1" events="44" subjects_affected="41" subjects_at_risk="974"/>
                <counts group_id="E2" events="52" subjects_affected="47" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Infection - Sternal wound infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="974"/>
                <counts group_id="E2" events="18" subjects_affected="14" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Infection - Urinary tract infection</sub_title>
                <counts group_id="E1" events="47" subjects_affected="40" subjects_at_risk="974"/>
                <counts group_id="E2" events="36" subjects_affected="31" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Access site and access related vascular injury - Aortic root rupture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="974"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Dissection</sub_title>
                <counts group_id="E1" events="21" subjects_affected="20" subjects_at_risk="974"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Access site/access related vascular injury - Distal embolization (noncerebral) from vascular source</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="974"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Access site/related vascular injury - Failure of perc access site closure causing intervention</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="974"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Hematoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="974"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Perforation</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="974"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Pseudoaneurysm</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="974"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Rupture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="974"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="974"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Ventricular rupture (Apical rupture)</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="974"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Anesthesia related complication - Aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="974"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Anesthesia related complication - Confusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="974"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Anesthesia related complication - Dysphasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="974"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Anesthesia related complication - Other</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="974"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Miscellaneous - Fall</sub_title>
                <counts group_id="E1" events="26" subjects_affected="25" subjects_at_risk="974"/>
                <counts group_id="E2" events="34" subjects_affected="32" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Abnormal lab value</sub_title>
                <counts group_id="E1" events="28" subjects_affected="24" subjects_at_risk="974"/>
                <counts group_id="E2" events="46" subjects_affected="42" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal - Fracture</sub_title>
                <counts group_id="E1" events="51" subjects_affected="47" subjects_at_risk="974"/>
                <counts group_id="E2" events="45" subjects_affected="43" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Musculoskeletal - Pain</sub_title>
                <counts group_id="E1" events="35" subjects_affected="33" subjects_at_risk="974"/>
                <counts group_id="E2" events="35" subjects_affected="32" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Miscellaneous - Cancer</sub_title>
                <counts group_id="E1" events="31" subjects_affected="27" subjects_at_risk="974"/>
                <counts group_id="E2" events="28" subjects_affected="26" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="974"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Mental state change (not neurological) - Dementia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="974"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Neurological - Change in level of consciousness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="974"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Neurological - Dysphasia/Aphasia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="974"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Neurological - Hemianopia (blindness in one half of the visual field)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="974"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Neurological - Hemiparesis (One sided body weakness)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="974"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Neurological - Hemiplegia (One side limb weakness)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="974"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Neurological - Hemorrhagic stroke</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="974"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Neurological - Ischemic stroke</sub_title>
                <counts group_id="E1" events="58" subjects_affected="57" subjects_at_risk="974"/>
                <counts group_id="E2" events="47" subjects_affected="46" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Neurological - Other</sub_title>
                <counts group_id="E1" events="20" subjects_affected="18" subjects_at_risk="974"/>
                <counts group_id="E2" events="25" subjects_affected="24" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Neurological - Other new neurological sign consistent with stroke</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="974"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Neurological - Syncope</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="974"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Neurological - TIA</sub_title>
                <counts group_id="E1" events="23" subjects_affected="22" subjects_at_risk="974"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Neurological - Undetermined stroke</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="974"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="974"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Mental state change (not neurological) - Confusion</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="974"/>
                <counts group_id="E2" events="16" subjects_affected="14" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Mental state change (not neurological) - Depression</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="974"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Neurological - Cognitive impairment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="974"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Genito-Urinary event - Non-hemorrhagic</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="974"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Renal insufficiency or renal failure</sub_title>
                <counts group_id="E1" events="53" subjects_affected="48" subjects_at_risk="974"/>
                <counts group_id="E2" events="88" subjects_affected="80" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respiratory event - Aspiration</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="974"/>
                <counts group_id="E2" events="10" subjects_affected="7" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Respiratory event - Atelectasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="974"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Respiratory event - Dyspnea</sub_title>
                <counts group_id="E1" events="20" subjects_affected="18" subjects_at_risk="974"/>
                <counts group_id="E2" events="24" subjects_affected="21" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Respiratory event - Other</sub_title>
                <counts group_id="E1" events="25" subjects_affected="23" subjects_at_risk="974"/>
                <counts group_id="E2" events="19" subjects_affected="18" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Respiratory event - Pneumothorax</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="974"/>
                <counts group_id="E2" events="18" subjects_affected="16" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Respiratory event - Pulmonary edema</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="974"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Respiratory event - Pulmonary effusion</sub_title>
                <counts group_id="E1" events="37" subjects_affected="33" subjects_at_risk="974"/>
                <counts group_id="E2" events="81" subjects_affected="64" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Respiratory event - Respiratory failure</sub_title>
                <counts group_id="E1" events="56" subjects_affected="50" subjects_at_risk="974"/>
                <counts group_id="E2" events="92" subjects_affected="75" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding - Hemorrhage</sub_title>
                <counts group_id="E1" events="167" subjects_affected="145" subjects_at_risk="974"/>
                <counts group_id="E2" events="297" subjects_affected="248" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Embolization including air/calcific valve material or Thrombus</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="974"/>
                <counts group_id="E2" events="27" subjects_affected="26" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="974"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="974"/>
                <counts group_id="E2" events="25" subjects_affected="24" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Ischemia</sub_title>
                <counts group_id="E1" events="20" subjects_affected="13" subjects_at_risk="974"/>
                <counts group_id="E2" events="24" subjects_affected="21" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="22" subjects_affected="21" subjects_at_risk="974"/>
                <counts group_id="E2" events="22" subjects_affected="20" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 10.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="838" subjects_at_risk="974"/>
                <counts group_id="E2" subjects_affected="864" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia/Hemolytic anemia</sub_title>
                <counts group_id="E1" events="192" subjects_affected="168" subjects_at_risk="974"/>
                <counts group_id="E2" events="219" subjects_affected="198" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="126" subjects_affected="120" subjects_at_risk="974"/>
                <counts group_id="E2" events="217" subjects_affected="210" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Arrhythmia/Conduction system injury (defect)</sub_title>
                <counts group_id="E1" events="338" subjects_affected="284" subjects_at_risk="974"/>
                <counts group_id="E2" events="507" subjects_affected="409" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Heart failure/CHF/Low output failure</sub_title>
                <counts group_id="E1" events="75" subjects_affected="71" subjects_at_risk="974"/>
                <counts group_id="E2" events="101" subjects_affected="90" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastro Intestinal event - Non-hemorrhagic</sub_title>
                <counts group_id="E1" events="108" subjects_affected="96" subjects_at_risk="974"/>
                <counts group_id="E2" events="157" subjects_affected="125" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Edema</sub_title>
                <counts group_id="E1" events="40" subjects_affected="39" subjects_at_risk="974"/>
                <counts group_id="E2" events="56" subjects_affected="53" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Miscellaneous - Other</sub_title>
                <counts group_id="E1" events="72" subjects_affected="62" subjects_at_risk="974"/>
                <counts group_id="E2" events="81" subjects_affected="67" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" events="213" subjects_affected="165" subjects_at_risk="974"/>
                <counts group_id="E2" events="221" subjects_affected="175" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection - Other</sub_title>
                <counts group_id="E1" events="96" subjects_affected="86" subjects_at_risk="974"/>
                <counts group_id="E2" events="96" subjects_affected="84" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Infection - Respiratory infection</sub_title>
                <counts group_id="E1" events="112" subjects_affected="98" subjects_at_risk="974"/>
                <counts group_id="E2" events="118" subjects_affected="101" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Infection - Urinary tract infection</sub_title>
                <counts group_id="E1" events="164" subjects_affected="133" subjects_at_risk="974"/>
                <counts group_id="E2" events="198" subjects_affected="165" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Miscellaneous - Fall</sub_title>
                <counts group_id="E1" events="94" subjects_affected="80" subjects_at_risk="974"/>
                <counts group_id="E2" events="76" subjects_affected="66" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Abnormal lab value</sub_title>
                <counts group_id="E1" events="260" subjects_affected="187" subjects_at_risk="974"/>
                <counts group_id="E2" events="404" subjects_affected="257" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal - Pain</sub_title>
                <counts group_id="E1" events="121" subjects_affected="100" subjects_at_risk="974"/>
                <counts group_id="E2" events="108" subjects_affected="90" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Mental state change (not neurological) - Confusion</sub_title>
                <counts group_id="E1" events="42" subjects_affected="39" subjects_at_risk="974"/>
                <counts group_id="E2" events="65" subjects_affected="63" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Genito-Urinary event - Non-hemorrhagic</sub_title>
                <counts group_id="E1" events="54" subjects_affected="47" subjects_at_risk="974"/>
                <counts group_id="E2" events="64" subjects_affected="58" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Renal insufficiency or renal failure</sub_title>
                <counts group_id="E1" events="254" subjects_affected="214" subjects_at_risk="974"/>
                <counts group_id="E2" events="297" subjects_affected="258" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respiratory event - Atelectasis</sub_title>
                <counts group_id="E1" events="37" subjects_affected="37" subjects_at_risk="974"/>
                <counts group_id="E2" events="51" subjects_affected="51" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Respiratory event - Pneumothorax</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="974"/>
                <counts group_id="E2" events="49" subjects_affected="47" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Respiratory Event - Pulmonary Effusion</sub_title>
                <counts group_id="E1" events="75" subjects_affected="70" subjects_at_risk="974"/>
                <counts group_id="E2" events="191" subjects_affected="178" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding - Hemorrhage</sub_title>
                <counts group_id="E1" events="345" subjects_affected="285" subjects_at_risk="974"/>
                <counts group_id="E2" events="500" subjects_affected="421" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="75" subjects_affected="74" subjects_at_risk="974"/>
                <counts group_id="E2" events="49" subjects_affected="48" subjects_at_risk="936"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="62" subjects_affected="56" subjects_at_risk="974"/>
                <counts group_id="E2" events="102" subjects_affected="97" subjects_at_risk="936"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Tenley Koepnick</name_or_title>
      <organization>Edwards Lifesciences</organization>
      <email>Tenley_Koepnick@edwards.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

